Search

Returning search results with filters:

Issue: COVID Clear all

Type

Audience

Category

Issue

Last updated

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.

Displaying 1 - 2 of 2 items.

Health alert or recall Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
… Key messages A potential risk of treatment failure of bamlanivimab against certain severe acute respiratory … variants was identified through global surveillance. Bamlanivimab is expected to retain neutralizing activity … variant. Healthcare professionals are advised that: Bamlanivimab, in in vitro assays, exhibited reduced activity …
AlertHealth professional risk communication | 2021-04-28
Health alert or recall Authorization of Bamlanivimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
… room (ER) physicians. Key messages On November 20, 2020, bamlanivimab was authorized for use in accordance with the … and Advertising of Drugs for Use in Relation to COVID-19 . Bamlanivimab is indicated for the treatment of adults and … labelling in order to expedite the global distribution of bamlanivimab. Healthcare professionals are advised that: …
AlertHealth professional risk communication | 2020-12-18
Report a problem or mistake on this page
What was wrong?

You will not receive a reply. Telephone numbers and e-mail addresses will be removed.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.